Evidence map›Paper›PMID 26768311›Full record

ArticleProteomics. Clinical applications2015

Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules.

Charles T Spencer, Jelena S Bezbradica, Mireya G Ramos, Chenoa D Arico, Stephanie B Conant, Pavlo Gilchuk, Jennifer J Gray, Mu Zheng, Xinnan Niu, William Hildebrand and 2 more

Abstract read
In one paragraph

Article in Proteomics. Clinical applications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Computational identification of cross-reactive TCR epitopes with ARDitox.Journal of cancer research and clinical oncology · 2025
    Article
  6. Review
  7. Review
  8. Sterile production of interferons in the thymus.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Review
  9. Review
  10. Article
  11. How persistent infection overcomes peripheral tolerance mechanisms to cause T cell-mediated autoimmune disease.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Charles T SpencerDepartment of Biological Sciences, University of Texas at El Paso, El Paso, TX, USA.
Jelena S BezbradicaInstitute for Molecular Bioscience, University of Queensland, Brisbane, Australia.
Mireya G RamosDepartment of Biological Sciences, University of Texas at El Paso, El Paso, TX, USA.
Chenoa D AricoDepartment of Biological Sciences, University of Texas at El Paso, El Paso, TX, USA.
Stephanie B ConantDepartment of Pathology, Microbiology and Immunology, Nashville, TN, USA.
Pavlo GilchukDepartment of Pathology, Microbiology and Immunology, Nashville, TN, USA.
Jennifer J GrayDepartment of Pathology, Microbiology and Immunology, Nashville, TN, USA.
Mu ZhengDepartment of Pathology, Microbiology and Immunology, Nashville, TN, USA.
Xinnan NiuDepartment of Pathology, Microbiology and Immunology, Nashville, TN, USA.
William HildebrandDepartment of Microbiology and Immunology, University of Oklahoma Health Science Centre, Oklahoma City, OK, USA.
Andrew J LinkDepartment of Pathology, Microbiology and Immunology, Nashville, TN, USA.
Sebastian JoyceDepartment of Pathology, Microbiology and Immunology, Nashville, TN, USA.
Nashville Oncology Associates · USThe University of Texas at El Paso · USUniversity of Oklahoma Health Sciences Center · USUniversity of Queensland · AU

Funding

TCCG12MD007592 · NIMHD · UNIVERSITY OF TEXAS EL PASO · PI KIRKEN, ROBERT A. · 2012 to 2018
$19.4M
MOLECULAR IMMUNOLOGY OF MINOR HISTOCOMPATIBILITY ANTIGENR01HL054977 · NHLBI · VANDERBILT UNIVERSITY · PI JOYCE, SEBASTIAN · 1995 to 2009
$2.6M
Processing and Presentation of Minor Histocompatibility Antigens that Cause GvHDR01HL121139 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JOYCE, SEBASTIAN · 2014 to 2017
$1.6M
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and AdjuvantI01BX001444 · VA · VETERANS HEALTH ADMINISTRATION · PI JOYCE, SEBASTIAN · 2014 to 2022
–
BLRD VA I01 BX001444NHLBI NIH HHS HL054977NHLBI NIH HHS HL121139NHLBI NIH HHS R01 HL054977NHLBI NIH HHS R01 HL121139NIAID NIH HHS N01 AI040079NIMHD NIH HHS 2G12MD007592NIMHD NIH HHS G12 MD007592
6 · The paper itself

Abstract

purposeMHC class I presentation of peptides allows T cells to survey the cytoplasmic protein milieu of host cells. During infection, presentation of self peptides is, in part, replaced by presentation of microbial peptides. However, little is known about the self peptides presented during infection, despite the fact that microbial infections alter host cell gene expression patterns and protein metabolism. EXPERIMENTAL

designThe self peptide repertoire presented by HLA-A*01;01, HLA-A*02;01, HLA-B*07;02, HLA-B*35;01, and HLA-B*45;01 (where HLA is human leukocyte antigen) was determined by tandem MS before and after vaccinia virus infection.

resultsWe observed a profound alteration in the self peptide repertoire with hundreds of self peptides uniquely presented after infection for which we have coined the term "self peptidome shift." The fraction of novel self peptides presented following infection varied for different HLA class I molecules. A large part (approximately 40%) of the self peptidome shift arose from peptides derived from type I interferon-inducible genes, consistent with cellular responses to viral infection. Interestingly, approximately 12% of self peptides presented after infection showed allelic variation when searched against approximately 300 human genomes. CONCLUSION AND CLINICAL RELEVANCE: Self peptidome shift in a clinical transplant setting could result in alloreactivity by presenting new self peptides in the context of infection-induced inflammation.

Indexed as

Antigen PresentationAmino Acid SequenceCell LineHistocompatibility Antigens Class IHumansMolecular Sequence DataOncogenesPeptidesProteomicsVaccinia virusHistocompatibility Antigens Class IPeptidesInfectionMinor histocompatibilityPeptidomeSelf peptidesTransplantation

Identifiers

PMID26768311
PMCPMC4920078
OpenAlexW1933245690

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.